- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
HVAX Technologies delivered strong FY25 results: Total Income surged 22% YoY to ₹131.42 Cr, Net Profit jumped almost 30% to ₹11.04 Cr, and EBITDA grew over 31% to ₹18.97 Cr. International revenue accounts for 17% of the total in FY25.
The company is strategically expanding globally, entering Mauritius & Qatar in FY25, and boosting its footprint in MENA & Africa. Key growth initiatives include advanced modular cleanrooms, AI & Far-UVC sterilization, and IoT-enabled contamination control. HVAX also aims to diversify from pharma into healthcare, solar, and semiconductors.
FY25 saw a major milestone with its successful NSE Emerge listing.
Financial highlights for FY25 include a healthy 15.34% Return on Equity and an improved Debt-to-Equity ratio of 0.39.
Management is confident in its strategic direction, planning strategic acquisitions in FY26 and projecting 35-40% CAGR, driven by an asset-light model and IPO funding. HVAX continues to prioritize precision and quality.